查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631481

冠狀動脈支架市場規模、佔有率、趨勢分析報告：按產品、最終用途、地區、細分市場預測，2025-2030 年

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents (BMS), Drug Eluting Stents (DES), Bioresorbable Vascular Scaffold), By End Use (Inpatient and Outpatient Facilities), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

冠狀動脈支架市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，到 2030 年全球冠狀動脈支架市場規模預計將達到 97 億美元。預計 2025 年至 2030 年間市場複合年成長率將達到 2.6%。預計未來幾年微創手術和經皮冠狀動脈介入治療 (PCI) 程序的普及將推動市場的發展。例如，根據《韓國胸腔心臟血管外科雜誌》的報告，2016年冠狀動脈疾病（CAD）的PCI率為78%，全國PCI率為96%，均明顯高於全球平均。因此，隨著 CAD 盛行率的不斷上升，預計在這些 CAD 患者中實施 PCI 的比例將會增加，從而推動對有效冠狀動脈支架技術的需求。

技術進步和第二代藥物釋放型支架的推出進一步推動了成長。例如，雅培實驗室的 XIENCE Sierra 於 2018 年 5 月成為美國首個核准用於 CTO 的 DES。美敦力公司於 2019 年初效仿，獲得 FDA核准其 Resolute 系列 DES 用於治療 CTO 適應症。此外，近期多家公司在美國推出了其冠狀動脈支架系統的新型版本，尤其是波士頓科學公司於 2021 年 1 月推出的 Synergy Megatron 和雅培實驗室於 2021 年 6 月推出的 XIENCE Skypoint。

COVID-19 疫情對冠狀動脈支架市場產生了不利影響。根據世界各地醫學協會的指導方針，手術延遲主要影響合格患者的非緊急和選擇性手術。例如，美國心臟學會（ACC）2020年指引建議在COVID-19疫情高峰期間延後非緊急程序，例如CTO介入和監測血管造影術。這些指南影響著世界各地醫生的治療決策。此外，根據歐洲心臟病學會的建議，在疫情尖峰時段，應繼續進行所有緊急和急診 PCI 手術（治療 STEMI、高風險或中危 NSTEMI、心源性休克和不穩定型心絞痛），而只有選擇性 PCI 手術（CTO 干預或治療 NYHA II 症狀）應推遲。

此外，預計緊急 PCI 手術的持續實施和非選擇性手術的運轉率提高將有助於冠狀動脈支架市場從 COVID-19 大流行中復甦。

冠狀動脈支架市場由公共醫療保險和醫療補助服務中心 (CMS) 和私人付款人提供的報銷推動。頸動脈支架置入術的保險覆蓋範圍是根據包括產品和服務供應商在內的全國範圍的覆蓋範圍決定的。從 2020 年 1 月開始，醫療保險和醫療補助服務中心 (CMS) 已提案對在門診手術中心 (ASC) 進行的部分血管成形術和支架置入術進行報銷，預計這將在預測期內增加市場收益。

冠狀動脈支架市場報告重點

  • 由於新技術和治療嚴重病變能力的提高，以及人口老化和合格PCI 治療的患者數量的增加，採用冠狀動脈支架裝置治療的 PCI 手術的總量將會增加。
  • 生物可吸收血管支架有望成為冠狀動脈疾病治療中成長第二快的領域，因為它具有多種優勢，例如可以暫時放置在患者心臟內，三年內分解從而有利於未來的治療，並且可以在患者體內完全溶解。
  • 良好的臨床試驗已經證明了 DES 相對於標準 BMS 的優越性。因此，DES 將在 2021 年佔據市場主導地位。
  • 北美將主導冠狀動脈支架市場，佔據 2024 年 43.6% 的最大收益佔有率。
  • 預計亞太地區冠狀動脈支架市場將出現最快的產生收入。市場受到其他變數的推動，例如 CAD篩檢的增加、經濟成長、監管更新以及澳大利亞和韓國等一些國家明顯優惠的報銷政策。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 冠狀動脈支架市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 冠狀動脈支架市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

第 4 章 冠狀動脈支架市場：按產品分類的估計和趨勢分析

  • 全球冠狀動脈支架市場：產品儀表板
  • 全球冠狀動脈支架市場：產品差異分析
  • 產品收益
  • 裸金屬支架
  • 藥物釋放型支架
  • 生物可吸收血管支架 (BVS)/生物可吸收冠狀動脈支架

5. 冠狀動脈支架市場：依最終用途的估計和趨勢分析

  • 全球冠狀動脈支架市場：最終用途儀表板
  • 全球冠狀動脈支架市場：最終用途差異分析
  • 按最終用途分類的收益
  • 住院設施
  • 門診設施

6. 冠狀動脈支架市場：按地區、產品和最終用途的估計和趨勢分析

  • 區域控制面板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 公司/競爭對手分類
  • 供應商概況
    • 2024 年主要企業的市場佔有率分析
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Terumo Corporation
    • B Braun SE
    • BIoTronik.
    • Stentys SA
    • MicroPort Scientific Corporation
    • CR Bard, Inc.
    • Cook Medical
Product Code: GVR-1-68038-106-1

Coronary Stents Market Growth & Trends:

The global coronary stents market size is expected to reach USD 9.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.6% from 2025 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology.

Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021.

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period.

Coronary Stents Market Report Highlights:

  • Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions
  • The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.
  • Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market
  • North America dominated the coronary stents market and accounted for the largest revenue share of 43.6% in 2024 and is anticipated to witness the same trend over the foreseeable future.
  • The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some countries such as Australia and South Korea.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary Stents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cardiovascular diseases
      • 3.2.1.2. Technological advancements in stent designs
      • 3.2.1.3. Increasing healthcare access and awareness
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced stents
      • 3.2.2.2. Risk of complications and side effects
  • 3.3. Coronary Stents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Coronary Stents Market: Product Estimates & Trend Analysis

  • 4.1. Global Coronary Stents Market: Product Dashboard
  • 4.2. Global Coronary Stents Market: Product Movement Analysis
  • 4.3. Global Coronary Stents Market by Product, Revenue
  • 4.4. Bare Metal Stents
    • 4.4.1. Bare metal stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Drug Eluting Stents
    • 4.5.1. Drug eluting stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Bioresorbable Vascular Scaffolds (BVS)/Bioresorbable Coronary Stents
    • 4.6.1. Bioresorbable vascular scaffolds (BVS)/bioresorbable coronary stents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Coronary Stents Market: End Use Estimates & Trend Analysis

  • 5.1. Global Coronary Stents Market: End Use Dashboard
  • 5.2. Global Coronary Stents Market: End Use Movement Analysis
  • 5.3. Global Coronary Stents Market Estimates and Forecasts, by End Use, Revenue (USD Million)
  • 5.4. Inpatient Facilities
    • 5.4.1. Inpatient facilities market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Outpatient Facilities
    • 5.5.1. Outpatient facilities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Coronary Stents Market: Regional Estimates & Trend Analysis by Product and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait coronary stents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. Key company market share analysis, 2024
    • 7.2.2. Abbott
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Medtronic
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Boston Scientific Corporation
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Terumo Corporation
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. B Braun SE
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Biotronik.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Stentys SA
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. MicroPort Scientific Corporation
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. C.R. Bard, Inc.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Cook Medical
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 10 Mexico coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Germany coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 15 UK coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 17 France coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 18 France coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Italy coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 20 Italy coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Spain coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Spain coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Denmark coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Sweden coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Norway coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 32 China coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 33 China coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Japan coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 36 India coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 37 India coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 38 South Korea coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Australia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Thailand coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Latin America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 45 Latin America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 46 Latin America coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Brazil coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 48 Brazil coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Argentina coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 50 Argentina coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 51 MEA coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 53 MEA coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 54 South Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 55 South Africa coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 58 UAE coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 59 UAE coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait coronary stents market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Coronary stents market: market outlook
  • Fig. 7 Coronary stents competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Coronary stents market driver impact
  • Fig. 11 Coronary stents market restraint impact
  • Fig. 12 Coronary stents market: Product movement analysis
  • Fig. 13 Coronary stents market: Product outlook and key takeaways
  • Fig. 14 Bare metal stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Drug eluting stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Bioresorbable vascular scaffolds (BVS)/bioresorbable coronary stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Coronary stents market: End Use movement analysis
  • Fig. 18 Coronary stents market: End Use outlook and key takeaways
  • Fig. 19 Inpatient facilities coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Outpatient facilities coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Global coronary stents market: Regional movement analysis
  • Fig. 22 Global coronary stents market: Regional outlook and key takeaways
  • Fig. 23 Global coronary stents market share and leading players
  • Fig. 24 North America, by country
  • Fig. 25 North America coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. key country dynamics
  • Fig. 27 U.S. coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada key country dynamics
  • Fig. 29 Canada coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Mexico key country dynamics
  • Fig. 31 Mexico coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK key country dynamics
  • Fig. 34 UK coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany key country dynamics
  • Fig. 36 Germany coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France key country dynamics
  • Fig. 38 France coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy key country dynamics
  • Fig. 40 Italy coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain key country dynamics
  • Fig. 42 Spain coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark key country dynamics
  • Fig. 44 Denmark coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden key country dynamics
  • Fig. 46 Sweden coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Norway key country dynamics
  • Fig. 48 Norway coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China key country dynamics
  • Fig. 51 China coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Japan key country dynamics
  • Fig. 53 Japan coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 India key country dynamics
  • Fig. 55 India coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand key country dynamics
  • Fig. 57 Thailand coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea key country dynamics
  • Fig. 59 South Korea coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia key country dynamics
  • Fig. 61 Australia coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil key country dynamics
  • Fig. 64 Brazil coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina key country dynamics
  • Fig. 66 Argentina coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa key country dynamics
  • Fig. 69 South Africa coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia key country dynamics
  • Fig. 71 Saudi Arabia coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE key country dynamics
  • Fig. 73 UAE coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait key country dynamics
  • Fig. 75 Kuwait coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Market share of key market players- Coronary stents market